The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers

xlomafota13 shared this article with you from Inoreader The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers Via American Journal of Cancer Research Am J Cancer Res. 2021 Dec 15;11(12):5833-5855. eCollection 2021. ABSTRACT Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is widely known as a tumor suppressor gene. It is located on chromosome 10q23 with 200 kb, and has dual activity of both protein and lipid phosphatase. In addition, as a targeted gene in multiple pathways, PTEN has a variety of physiological activities, such as those regulating the cell cycle, inducing cell apoptosis, and inhibiting cell invasion, etc. The PTEN gene have been identified in many kinds of cancers due to its mutations, deletions and inactivation, such as lung cancer, liver cancer, and breast cancer, and they are closely connected with the genesis and progression of cancers. To a large extent, the tumor suppressive function of PTEN is realized through its inhibition of the PI3K/AKT signaling pathway which controls cells apoptosis and development. In addition, PTEN loss has been associate d with the prognosis of many cancers, such as lung cancer, liver cancer, and breast cancer. PTEN gene is related to many cancers and their pathological development. On the basis of a large number of related studies, this study describes in detail the structure, regulation, function and classical signal pathways of PTEN, as well as the relationship between various tumors related to PTEN. In addition, some drug studies targeting PTEN/PI3K/AKT/mTOR are also introduced in order to provide some directions for experimental research and clinical treatment of tumors. PMID:35018228 | PMC:PMC8727805 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.